Pharming Group NV purchased the remaining intellectual property assets of PPL Therapeutics plc from London-based Innovation Development Ltd., for what Chief Science and Technology Officer Frank Pieper called “a relatively small sum.”
Pharming Group NV purchased the remaining intellectual property assets of PPL Therapeutics plc from London-based Innovation Development Ltd., for what Chief Science and Technology Officer Frank Pieper called “a relatively small sum.”
